๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

โœ Scribed by F. F. POORDAD


Book ID
108605922
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
543 KB
Volume
31
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Rapid virological response and treatment
โœ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Chang-Fu Chiu; Yi-Hsin C. Yang; Nai-Je ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 310 KB ๐Ÿ‘ 1 views

Recommended treatment for hepatitis C virus genotype 1 (HCV-1) patients is peginterferon plus ribavirin for 48 weeks. We assessed whether treatment duration of 24 weeks is as effective as standard treatment in HCV-1 patients with a rapid virological response (RVR; seronegative for hepatitis C virus

The importance of the definition of earl
โœ Ming-Lung Yu ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 378 KB

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Rapid virological response to peginterfe
โœ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Wan-Long Chuang ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB ๐Ÿ‘ 1 views

contraindicate the use of drugs such as hydroxymethyl-glutaryl-coenzyme A inhibitors (statins). Statins, as the most popular cholesterollowering agents, are widely used in the MS and display in vitro anti-HCV properties. 6 However, results from an in vivo pilot study with atorvastatin have been disa

Pegylated interferon alpha-2b plus ribav
โœ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 251 KB ๐Ÿ‘ 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated